Cargando…

A case report of cholangiocarcinoma combined with moderately differentiated gastric adenocarcinoma

RATIONALE: Multiple primary carcinoma (MPM) refers to simultaneous or successive occurrence of ≥2 types of primary malignant tumors in a single organ or in different organs of the same individual. It is rarely seen in clinical practice. Among the various types of MPM, hilar cholangiocarcinoma combin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yan-Hui, Deng, Qing, Yang, Tian-Bao, Gui, Yang, Zhang, Yu-xiang, Liu, Jiang-Bo, Deng, Qian, Liu, Wei-Feng, Sun, Jun-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709107/ https://www.ncbi.nlm.nih.gov/pubmed/31348232 http://dx.doi.org/10.1097/MD.0000000000016332

Ejemplares similares

Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma
por: Xiao, Jing-Bo, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

Identification of Cholangiocarcinoma Associated with Hepatolithiasis via the Combination of miRNA and Ultrasound
por: Jiang, Wei, et al.
Publicado: (2020)

BIX‐01294 enhanced chemotherapy effect in gastric cancer by inducing GSDME‐mediated pyroptosis
por: Deng, Bei‐Bei, et al.
Publicado: (2020)

Reactivation of microRNA-506 inhibits gastric carcinoma cell metastasis through ZEB2
por: Wang, Gui-Jun, et al.
Publicado: (2019)

Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Yang, Jie, et al.
Publicado: (2020)

A nomogram based on ultrasonographic features and clinical indicators for differentiating mass-forming intrahepatic cholangiocarcinoma and liver metastatic colorectal adenocarcinoma
por: Bao, Wuyongga, et al.
Publicado: (2023)

Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy
por: Deng, Gang, et al.
Publicado: (2023)

Circ_0000190 suppresses gastric cancer progression potentially via inhibiting miR-1252/PAK3 pathway
por: Wang, Gui-Jun, et al.
Publicado: (2020)

Research on the Histological Features and Pathological Types of Gastric Adenocarcinoma With Mucinous Differentiation
por: Meng, Nian-Long, et al.
Publicado: (2022)

Comparative analysis of gene expression profiles of gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma
por: Song, Bin, et al.
Publicado: (2016)

Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma
por: Zhao, Linghao, et al.
Publicado: (2022)

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma
por: Yang, Guo-Wei, et al.
Publicado: (2015)

Camrelizumab combined with apatinib and S-1 as second-line treatment for patients with advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study
por: Jing, Chao, et al.
Publicado: (2022)

Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges
por: Yang, Yang, et al.
Publicado: (2020)

PTPRF as a novel tumor suppressor through deactivation of ERK1/2 signaling in gastric adenocarcinoma
por: Tian, Xiang’an, et al.
Publicado: (2018)

A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2018)

A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Abnormal Exacerbation of Moderately Differentiated Gastric Adenocarcinoma in a Patient with TAFRO Syndrome: An Impaired Tumor Immunity?
por: Inano, Tadaaki, et al.
Publicado: (2022)

Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma
por: Bian, Tingting, et al.
Publicado: (2017)

Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators
por: Chen, Yanling, et al.
Publicado: (2022)

Biliary stenting alone versus biliary stenting combined with (125)I particles intracavitary irradiation for the treatment of advanced cholangiocarcinoma
por: Pang, Qing, et al.
Publicado: (2019)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Adenocarcinoma with Mixed Subtypes in the Early and Advanced Gastric Cancer
por: Zhao, Xixian, et al.
Publicado: (2021)

The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome
por: Zheng, Bo‐Hao, et al.
Publicado: (2020)

Macrophages-aPKC(ɩ)-CCL5 Feedback Loop Modulates the Progression and Chemoresistance in Cholangiocarcinoma
por: Yang, Tao, et al.
Publicado: (2022)

Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma
por: Cheng, Jun, et al.
Publicado: (2022)

Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram
por: Wu, Zi-You, et al.
Publicado: (2020)

A unique case of well-differentiated gastric-type adenocarcinoma coexisting with a gastric adenocarcinoma of the fundic gland in a Helicobacter pylori-uninfected stomach
por: Dong, Zhixia, et al.
Publicado: (2023)

Survival outcomes of combined hepatocellular‐cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population‐based cohort study
por: Yang, Zhen, et al.
Publicado: (2021)

Prognostic Immunity and Therapeutic Sensitivity Analyses Based on Differential Genomic Instability-Associated LncRNAs in Left- and Right-Sided Colon Adenocarcinoma
por: Guo, Jun-Nan, et al.
Publicado: (2021)

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
por: Han, Deng, et al.
Publicado: (2021)

Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study
por: Zhang, Ge, et al.
Publicado: (2022)

The Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma Cells
por: Liu, Ning, et al.
Publicado: (2015)

The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma
por: Qian, Men-Bao, et al.
Publicado: (2012)

Expression and clinical significance of fibroblast growth factor 1 in gastric adenocarcinoma
por: Liu, Naiqing, et al.
Publicado: (2015)

A case report of rectal adenocarcinoma with intrahepatic cholangiocarcinoma of the liver
por: Guo, Jing-qiang, et al.
Publicado: (2019)

Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection
por: Cheng, Yan, et al.
Publicado: (2007)

Enhancement of Radiation Effects by Ursolic Acid in BGC-823 Human Adenocarcinoma Gastric Cancer Cell Line
por: Yang, Yang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ou60kusrpgb425ee2qbemi39vd